TRADE POLICY | 2026-07-16
Section 232 Pharmaceutical Tariffs: 100% Rate July 31, 2026
A presidential proclamation issued April 2, 2026, under Section 232 of the Trade Expansion Act imposes a default 100% ad valorem tariff on imported patented pharmaceuticals and active pharmaceutical ingredients, with the first effective date arriving July 31, 2026.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
On April 2, 2026, President Donald Trump issued a presidential proclamation invoking Section 232 of the Trade Expansion Act of 1962, codified at 19 U.S.C. Section 1862, to impose tariffs on imports of certain pharmaceuticals and active pharmaceutical ingredients on national-security grounds. The default rate is 100 percent ad valorem, applying to patented drugs listed in the FDA's Orange Book or Purple Book, active pharmaceutical ingredients, and key starting materials, effective July 31, 2026 f
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301